首页|NIR-Ⅱb-triggered photodynamic therapy combined with chemotherapy platform based on rare-earth-doped nanoparticles
NIR-Ⅱb-triggered photodynamic therapy combined with chemotherapy platform based on rare-earth-doped nanoparticles
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
万方数据
Photodynamic therapy(PDT),with high spa-tiotemporal selectivity,minimal side effects and less drug resistance,has emerged as a promising approach for the treatment of cancer.However,inadequate penetration depth and poor efficacy seriously restrict its practical application.To address these challenges,we developed a combined therapy platform(RENP@C/D-FA)based on rare-earth-doped nanoparticles(RENPs)with a structure of NaErF4∶Tm(0.5%)@NaYF4,on which photosensitizer Ce6(chlorin e6)and chemo-therapeutic drug(DOX)(doxoru-bicin)were loaded by encapsulating with an amphiphilic polymer distearoyl phosphatidylethanolamine-poly-ethylene glycol-folic acid(DSPE-PEG-FA).RENPs with NaErF4 as the matrix possess multiple excitation/emission peaks,enabling activation of PDT under near-infrared-Ⅱb(NIR-Ⅱb,1500-1700 nm)excitation and luminescence imaging in NIR-Ⅱb region by absorbing 808 nm near-in-frared photons.Furthermore,DOX can be selectively released in the acidic microenvironment of tumors.Bene-fiting from the tumor targeting capability of folic acid,this platform can successfully ablate tumor cells and inhibit tumor growth by combining PDT and chemotherapy.This innovative approach holds great promise as a powerful tool for cancer treatment,showing the potential to revolutionize PDT.